Coronavirus (COVID-19) Update: Daily Roundup

SILVER SPRING, Md., April 6, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:

    --  On April 4, 2020, the FDA issued guidance on clinical electronic
        thermometers that immediately went into effect. Fever is a common
        symptom of COVID-19 and clinical electronic thermometers are an
        important screening and diagnostic tool to assist in the identification
        of those individuals who may be infected with COVID-19. The policy set
        forth in the guidance may help expand the availability of clinical
        electronic thermometers to address this public health emergency.

    --  On April 5, 2020, the FDA issued guidance on infusion pumps and
        accessories that immediately went into effect. The guidance aims to help
        ensure the availability of infusion pumps and accessories for patients
        who require continuous infusion of medications, nutrition, and other
        fluids and help foster technologies, such as remote capabilities, that
        maintain a safer physical distance between the health care provider and
        the patient.

    --  Diagnostics update to date:
        --  During the COVID-19 pandemic, the FDA has worked with more than 270
            test developers who have said they will be submitting emergency use
            authorizations (EUA) requests to FDA for tests that detect the
            virus.
        --  To date, 28 emergency use authorizations have been issued for
            diagnostic tests.
        --  The FDA has been notified that more than 145 laboratories have begun
            testing under the policies set forth in our COVID-19 Policy for
            Diagnostic Tests for Coronavirus Disease-2019 during the Public
            Health Emergency Guidance.
        --  The FDA also continues to keep its COVID-19 Diagnostics FAQ up to
            date.

Additional Resources:

    --  Coronavirus Disease 2019 (COVID-19)

Media Contact: Molly Block, 240-701-7422
Consumer Inquiries: 888-INFO-FDA

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

View original content to download multimedia:http://www.prnewswire.com/news-releases/coronavirus-covid-19-update-daily-roundup-301036243.html

SOURCE U.S. Food and Drug Administration